Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Webinar: Keeping Claims on Track During COVID-19
Case management provides a crucial role in keeping claims on track and achieving return to work or maximum medical improvement.
Podcast: Michele Hibbert-Iacobacci Talks Michigan No-Fault Reform With AM Best Radio
Hear about the new Michigan fee schedule, policy limits and more.
AM Best: COVID-19 Influence on Workers' Compensation Could Be a Lasting Market Changer
In this interview, Mitchell VP Michele Hibbert-Iacobacci shares how COVID-19 is impacting the industry.
WorkCompWire: When Red Flags Appear, IMEs Provide Insight to Take the Next Step on a Claim
Even in midst of the COVID-19 pandemic, independent medical examinations (IMEs) remain an important part in moving claims forward and making sure the injured worker is on the right path to recovery.
Find Nearby Diagnostic Scanning Services
As a provider of diagnostic scanning and calibration tools, Mitchell would like to help match those who have in-house diagnostic devices and capabilities with those who may need services. Use the locator to find a facility near you, or add your facility to the lookup.
2020 mPower Virtual Conference
Over the past several months, the Mitchell | Genex teams have been closely monitoring the developments surrounding COVID-19 and the CDC’s recommend